Bladder Cancer Navigation at Scale

A large urology group uses Clinical-i to monitor active bladder cancer patients, surface care gaps, and support navigator action across multiple locations.

Request A Demo
8845

Active bladder cancer patients monitored

50

Locations represented

338 / 568

Interventions / notes recorded

961

Close events recorded

EXECUTIVE STATEMENT

A large multi-site urology group uses Clinical-i to continuously monitor 8,845 active bladder cancer patients across 50+ locations.

Clinical-i converts fragmented bladder cancer data into prioritized work — surveillance gaps, BCG maintenance needs, reminders, navigator action, patient engagement, and documented closure.

The story

From invisible work to an auditable operating model

Problem Statment

Bladder cancer care depends on linked steps, but the data guiding each step is scattered.
  • Pathology, cystoscopy, imaging, BCG history, and notes often live in different places.
  • Risk, stage, prior therapy, and timing determine what comes next.
  • Navigators spend time hunting through charts to determine who needs action.
  • Missed data can lead to missed surveillance, delayed treatment, or lost follow-up.

Consequences

The patient may be seen, but the next required bladder cancer action can still be missed.
  • Surveillance cystoscopy, imaging, treatment, or follow-up may become overdue.
  • Navigator time shifts from patient intervention to chart hunting.
  • BCG maintenance, reminders, and open surveillance tasks remain difficult to track.
  • Therapy and trial opportunities can stay hidden in existing data.

Continuous Bladder Cancer Execution Loop

Our Solution

Clinical-i turns scattered bladder cancer data into continuous monitoring and prioritized action.
  • Identifies and stratifies bladder cancer patients.
  • Applies risk, stage, treatment history, and clinic logic.
  • Surfaces overdue surveillance, BCG needs, reminders, and follow-up gaps.
  • Routes work to navigators for outreach, escalation, documentation, and closure.
Results + Measurability

Every stage leaves a measurable operational footprint.

71

Surveillance due

276

BCG Maintenance Open

325

Reminders Open

79

Surveillance tasks

Measured as queues, engagement, messages, status changes, and closure — by location, provider, and workflow.

Conclusion

Bladder cancer is complex. Clinical-i helps clinics manage it as a continuous, trackable workflow.

  • Finds patients who need attention.
  • Identifies what is due, missed, or overdue.
  • Supports navigator outreach, escalation, and closure.
  • Creates measurable visibility across locations, providers, and workflows.

Clinical

Fewer hidden gaps and better guideline-driven prioritization.

Operational

Less chart hunting and a scalable navigator workflow.

Financial

Makes surveillance, treatment, testing, and trial opportunities easier to identify and act on.

let's connect

Ready to Close the Loop?

Let’s build a care system where every test, follow-up, and communication is tracked — for better care and stronger risk management.

Request A Demo